Targeted intracellular delivery of resveratrol to glioblastoma cells using apolipoprotein E-containing reconstituted HDL as a nanovehicle.

Targeted intracellular delivery of resveratrol to glioblastoma cells using apolipoprotein E-containing reconstituted HDL as a nanovehicle.
复制标题

DOI:
10.1371/journal.pone.0135130
复制
发表时间:
2015
期刊:
影响因子:
3.7
通讯作者:
Narayanaswami V
Narayanaswami V
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Kim SH;Adhikari BB;Cruz S;Schramm MP;Vinson JA;Narayanaswami V

文献摘要

被引文献

相似文献

本研究的目的是利用载脂蛋白E3(apoE 3)将白藜芦醇转运到细胞内位点。重组高密度脂蛋白(rHDL)轴承白藜芦醇(rHDL/res)的制备使用磷脂和低密度脂蛋白受体(LDLr)的apoE 3结合域。生物物理特性表明,白藜芦醇被分配到磷脂双层的盘状rHDL/res颗粒(约19 nm直径)。免疫共沉淀研究表明,保留了apoE 3的LDLR结合能力。在胶质母细胞瘤A-172细胞中,通过直接荧光使用化学合成的NBD标记的白藜芦醇(res/NBD)嵌入rHDL/res。竞争和抑制研究表明,白藜芦醇的摄取是通过受体介导的内吞作用通过LDLr,与晚期内体/溶酶体中的apoE 3和res/NBD的共定位。我们建议,rHDL提供了一个理想的疏水环境,螯合白藜芦醇和含有载脂蛋白E3的rHDL作为一个有效的“纳米载体”,运输和提供白藜芦醇的靶向细胞内位点。
The objective of this study is to transport and deliver resveratrol to intracellular sites using apolipoprotein E3 (apoE3). Reconstituted high-density lipoprotein (rHDL) bearing resveratrol (rHDL/res) was prepared using phospholipids and the low-density lipoprotein receptor (LDLr)-binding domain of apoE3. Biophysical characterization revealed that resveratrol was partitioned into the phospholipid bilayer of discoidal rHDL/res particles (~19 nm diameter). Co-immunoprecipitation studies indicated that the LDLr-binding ability of apoE3 was retained. Cellular uptake of resveratrol to intracellular sites was evaluated in glioblastoma A-172 cells by direct fluorescence using chemically synthesized NBD-labeled resveratrol (res/NBD) embedded in rHDL/res. Competition and inhibition studies indicate that the uptake is by receptor mediated endocytosis via the LDLr, with co-localization of apoE3 and res/NBD in late endosomes/lysosomes. We propose that rHDL provides an ideal hydrophobic milieu to sequester resveratrol and that rHDL containing apoE3 serves as an effective “nanovehicle” to transport and deliver resveratrol to targeted intracellular sites.